Overview

Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails

Status:
Recruiting

Trial end date:
2021-06-01

Target enrollment:

Participant gender:

Summary

The trial is conducted to investigate the clinical efficacy of a combination product containing calcipotriol and betamethasone formulated as an aerosol foam (Enstilar ©) for the treatment of nail psoriasis in conjunction with physical pre-treatment using a fractionally ablative carbon dioxide laser (AFL). It is hypothesized, based on preclinical data and comparable clinical trials, that laser processing prior to topical administration will lead to increased drug distribution, and thereby increase the efficacy of Enstilar® in treating nail psoriasis.

Phase:

Phase 2

Details

Lead Sponsor:

Bispebjerg Hospital

Collaborator:

LEO Innovation Lab

Treatments:

Calcipotriene